Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
David Eapen-John, Ayeshah G. Mohiuddin & James L. Kennedy. (2022) A potential paradigm shift in opioid crisis management: The role of pharmacogenomics. The World Journal of Biological Psychiatry 23:6, pages 411-423.
Read now
Read now
Malik Mumtaz Taqi, Muhammad Faisal & Hadar Zaman. (2019) OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. Pharmacogenomics and Personalized Medicine 12, pages 361-368.
Read now
Read now
Christoph Stein. (2018) New concepts in opioid analgesia. Expert Opinion on Investigational Drugs 27:10, pages 765-775.
Read now
Read now
Articles from other publishers (68)
Blessed W Aruldhas, Sara K Quinney, Senthil Packiasabapathy, Brian R Overholser, Olivia Raymond, Sahana Sivam, Inesh Sivam, Sanjana Velu, Antoinette Montelibano & Senthilkumar Sadhasivam. (2023) Effects of oxycodone pharmacogenetics on postoperative analgesia and related clinical outcomes in children: a pilot prospective study. Pharmacogenomics 24:4, pages 187-197.
Crossref
Crossref
Jeanette Tour, Angelica Sandström, Diana Kadetoff, Martin Schalling & Eva Kosek. (2022) The OPRM1 gene and interactions with the 5-HT1a gene regulate conditioned pain modulation in fibromyalgia patients and healthy controls. PLOS ONE 17:11, pages e0277427.
Crossref
Crossref
Liew Yee, Francis R Capule & Mohd Makmor-Bakry. (2022)
Genetic polymorphisms of
OPRM1
on the efficacy and safety of anesthetic and analgesic agents: a systematic review
. Pharmacogenomics 23:10, pages 609-617.
Crossref
Crossref
Jordi Barrachina, Cesar Margarit, Javier Muriel, Santiago López-Gil, Vicente López-Gil, Amaya Vara-González, Beatriz Planelles, María-del-Mar Inda, Domingo Morales & Ana M. Peiró. (2022) Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study. Scientific Reports 12:1.
Crossref
Crossref
Irina I. Belyaeva, Anna G. Subbotina, Ivan I. Eremenko, Vadim V. Tarasov, Vladimir N. Chubarev, Helgi B. Schiöth & Jessica Mwinyi. (2022) Pharmacogenetics in Primary Headache Disorders. Frontiers in Pharmacology 12.
Crossref
Crossref
Łukasz Zadroga, Elżbieta Grzywacz, Maria Grzymkowska, Jolanta Chmielowiec, Jolanta Masiak, Aleksandra Strońska-Pluta, Anna Grzywacz & Krzysztof Chmielowiec. (2022)
The role of the
OPRM1
gene polymorphism and its methylation in people in dependence on substances and with different intensity of pain
. Polish Journal of Public Health 132:1, pages 25-30.
Crossref
Crossref
Mongi Benjeddou & Ana M. Peiró. 2022. The Neurobiology, Physiology, and Psychology of Pain. The Neurobiology, Physiology, and Psychology of Pain
45
56
.
Aida A. Harutyunyan, Hayk A. Harutyunyan & Konstantin B. Yenkoyan. (2021) Novel Probable Glance at Inflammatory Scenario Development in Autistic Pathology. Frontiers in Psychiatry 12.
Crossref
Crossref
Marco Calapai, Emanuela Esposito, Luisa Puzzo, Daniele Alfio Vecchio, Rosario Blandino, Giuseppe Bova, Domenico Quattrone, Carmen Mannucci, Ilaria Ammendolia, Cristina Mondello, Sebastiano Gangemi, Gioacchino Calapai & Luigi Cardia. (2021) Post-Mastectomy Pain: An Updated Overview on Risk Factors, Predictors, and Markers. Life 11:10, pages 1026.
Crossref
Crossref
Kyeong Jin Yoon, Suhong Park, Seung Hee Kwak & Hyo Youl Moon. (2021) Effects of Voluntary Running Wheel Exercise-Induced Extracellular Vesicles on Anxiety. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Senthil Packiasabapathy, Blessed W Aruldhas, Pengyue Zhang, Brian R Overholser, Sara K Quinney & Senthilkumar Sadhasivam. (2021)
Novel associations between
CYP2B6
polymorphisms, perioperative methadone metabolism and clinical outcomes in children
. Pharmacogenomics 22:10, pages 591-602.
Crossref
Crossref
Orna Levran & Mary Jeanne Kreek. (2020) Population-specific genetic background for the OPRM1 variant rs1799971 (118A>G): implications for genomic medicine and functional analysis. Molecular Psychiatry 26:7, pages 3169-3177.
Crossref
Crossref
Nelly N Umukoro, Blessed W Aruldhas, Ryan Rossos, Dhanashri Pawale, Janelle S Renschler & Senthilkumar Sadhasivam. (2021) Pharmacogenomics of oxycodone: a narrative literature review. Pharmacogenomics 22:5, pages 275-290.
Crossref
Crossref
Javier Cuitavi, Lucía Hipólito & Meritxell Canals. (2021) The Life Cycle of the Mu-Opioid Receptor. Trends in Biochemical Sciences 46:4, pages 315-328.
Crossref
Crossref
Isabel Ellerbrock, Angelica Sandström, Jeanette Tour, Diana Kadetoff, Martin Schalling, Karin B. Jensen & Eva Kosek. (2020) Polymorphisms of the μ‐opioid receptor gene influence cerebral pain processing in fibromyalgia. European Journal of Pain 25:2, pages 398-414.
Crossref
Crossref
Prabha Udayakumar & Srisruthi Udayakumar. (2021) Fentanyl-induced respiratory depression: A narrative review on the possible single-nucleotide polymorphism. Anesthesia: Essays and Researches 15:1, pages 4.
Crossref
Crossref
Marcela Konjevod, Matea Nikolac Perkovic, Dubravka Svob Strac, Suzana Uzun, Gordana Nedic Erjavec, Oliver Kozumplik, Lucija Tudor, Ninoslav Mimica, Mika Hirasawa-Fujita, Edward F Domino & Nela Pivac. (2020) Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence. Psychiatry Research 291, pages 113278.
Crossref
Crossref
Dario Bugada, Luca F. Lorini, Roberto Fumagalli & Massimo Allegri. (2020) Genetics and Opioids: Towards More Appropriate Prescription in Cancer Pain. Cancers 12:7, pages 1951.
Crossref
Crossref
Devon Collins, Yong Zhang, Julie Blendy & Mary Jeanne Kreek. (2020) Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference. Neuropharmacology 167, pages 107864.
Crossref
Crossref
Bardia Varastehmoradi, Gregers Wegener, Connie Sanchez & Karen L. Smith. (2020) Opioid system modulation of cognitive affective bias: implications for the treatment of mood disorders. Behavioural Pharmacology 31:2&3, pages 122-135.
Crossref
Crossref
Senthil Packiasabapathy, Valluvan Rangasamy, Nicole Horn, Michele Hendrickson, Janelle Renschler & Senthilkumar Sadhasivam. (2020) Personalized pediatric anesthesia and pain management: problem-based review. Pharmacogenomics 21:1, pages 55-73.
Crossref
Crossref
Leila Mobasheri, Seyedeh Zahra Moossavi, Aliakbar Esmaeili, Milad Mohammadoo-khorasani & Gholamreza Anani Sarab. (2020) Association between vitamin D receptor gene FokI and TaqI variants with autism spectrum disorder predisposition in Iranian population. Gene 723, pages 144133.
Crossref
Crossref
Senthil Packiasabapathy, Michele Hendrickson & Senthilkumar Sadhasivam. 2020. Opioid Therapy in Infants, Children, and Adolescents. Opioid Therapy in Infants, Children, and Adolescents
95
110
.
Leda Marina Pomes, Martina Guglielmetti, Enrico Bertamino, Maurizio Simmaco, Marina Borro & Paolo Martelletti. (2019) Optimising migraine treatment: from drug-drug interactions to personalized medicine. The Journal of Headache and Pain 20:1.
Crossref
Crossref
S. Kumar, P. Kundra, K. Ramsamy & A. Surendiran. (2019) Pharmacogenetics of opioids: a narrative review. Anaesthesia 74:11, pages 1456-1470.
Crossref
Crossref
O. BARTOŠOVÁ, O. POLANECKÝ, R. ŠACHL, I. ŠTENGLOVÁ NETÍKOVÁ, F. PERLÍK, S. ADÁMEK, R. LISCHKE & O. SLANAŘ. (2019) Epidural Analgesia With Sufentanil in Relation to OPRM1 and ABCB1 Polymorphisms. Physiological Research, pages S59-S64.
Crossref
Crossref
A. L. Potapov, A. D. Kaprin, S. A. Ivanov, A. V. Boiarkina, N. Yu. Novikov, R. R. Gevorkyan & I. P. Kostyuk. (2019) Polymorphism of μ1-opioid receptor (OPRM1) gene may be of value in genesis of renal malignant neoplasm. Cancer Urology 15:3, pages 42-45.
Crossref
Crossref
Kyoung Min Kim, Sam-Wook Choi, Dohyun Kim, Jaewon Lee & Jun Won Kim. (2019) Associations among the opioid receptor gene (OPRM1) A118G polymorphism, psychiatric symptoms, and quantitative EEG in Korean males with gambling disorder: A pilot study. Journal of Behavioral Addictions 8:3, pages 463-470.
Crossref
Crossref
Brigitte George, Christian Minello, Gilles Allano, Caroline Maindet, Alexis Burnod & Antoine Lemaire. (2019) Opioids in cancer-related pain: current situation and outlook. Supportive Care in Cancer 27:8, pages 3105-3118.
Crossref
Crossref
Zhicao Yu, Lei Wen, Xingyong Shen & Hongmei Zhang. (2019) Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain. The Clinical Journal of Pain 35:1, pages 77-86.
Crossref
Crossref
Nicola Allegri, Simona Mennuni, Eliana Rulli, Nicola Vanacore, Oscar Corli, Irene Floriani, Irene De Simone, Massimo Allegri, Stefano Govoni, Tomaso Vecchi, Giorgio Sandrini, Davide Liccione & Elena Biagioli. (2018) Systematic Review and Meta‐Analysis on Neuropsychological Effects of Long‐Term Use of Opioids in Patients With Chronic Noncancer Pain. Pain Practice.
Crossref
Crossref
Lindsey C. Partington, Jessica L. Borelli, Patricia Smiley, Ella Jarvik, Hannah F. Rasmussen, Lauren C. Seaman & Erika L. Nurmi. (2018) Parental overcontrol x OPRM1 genotype interaction predicts school-aged children’s sympathetic nervous system activation in response to performance challenge. Research in Developmental Disabilities 82, pages 39-52.
Crossref
Crossref
Sameen Boparai, Jessica L. Borelli, Lindsey Partington, Patricia Smiley, Ella Jarvik, Hannah F. Rasmussen, Lauren C. Seaman & Erika L. Nurmi. (2018) Interaction between the Opioid Receptor OPRM1 Gene and Mother-Child Language Style Matching Prospectively Predicts Children’s Separation Anxiety Disorder Symptoms. Research in Developmental Disabilities 82, pages 120-131.
Crossref
Crossref
Devon Collins, Matthew Randesi, Joel Correa da Rosa, Yong Zhang & Mary Jeanne Kreek. (2018) Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice. Psychopharmacology 235:9, pages 2703-2711.
Crossref
Crossref
Nebojsa Knezevic, Tatiana Tverdohleb, Ivana Knezevic & Kenneth Candido. (2018) The Role of Genetic Polymorphisms in Chronic Pain Patients. International Journal of Molecular Sciences 19:6, pages 1707.
Crossref
Crossref
Ji Soo Lee, Jill L. Sorcher, Allison D. Rosen, Ruslan Damadzic, Hui Sun, Melanie Schwandt, Markus Heilig, John Kelly, Kelsey L. Mauro, Audrey Luo, Daniel Rosoff, Christine Muench, Jeesun Jung, Zachary A. Kaminsky & Falk W. Lohoff. (2018)
Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (
PIP5K1C
) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol Use
. Alcoholism: Clinical and Experimental Research 42:6, pages 1034-1043.
Crossref
Crossref
Linda A. Hatfield, Rebecca K. Hoffman, Rosemary C. Polomano & Yvette Conley. (2018) Epigenetic Modifications Following Noxious Stimuli in Infants. Biological Research For Nursing 20:2, pages 137-144.
Crossref
Crossref
Francina Fonseca & Marta Torrens. (2017) Pharmacogenetics of Methadone Response. Molecular Diagnosis & Therapy 22:1, pages 57-78.
Crossref
Crossref
Jean-Marc Cavaillon & Mervyn SingerChristoph Stein. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
891
914
.
Anna Cieślińska, Elżbieta Kostyra, Barbara Chwała, Małgorzata Moszyńska-Dumara, Ewa Fiedorowicz, Małgorzata Teodorowicz & Huub Savelkoul. (2017) Vitamin D Receptor Gene Polymorphisms Associated with Childhood Autism. Brain Sciences 7:12, pages 115.
Crossref
Crossref
Maja Matic, Joost LM Jongen, Laure Elens, Saskia N de Wildt, Dick Tibboel, Peter AE Sillevis Smitt & Ron HN van Schaik. (2017) Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement. Pharmacogenomics 18:12, pages 1133-1142.
Crossref
Crossref
Maja Matic, Saskia N de Wildt, Dick Tibboel & Ron H N van Schaik. (2017) Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice. Clinical Chemistry 63:7, pages 1204-1213.
Crossref
Crossref
Jeanette Tour, Monika Löfgren, Kaisa Mannerkorpi, Björn Gerdle, Anette Larsson, Annie Palstam, Indre Bileviciute-Ljungar, Jan Bjersing, Ingvar Martin, Malin Ernberg, Martin Schalling & Eva Kosek. (2017) Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls—antagonistic effects between opioid and serotonin-related genes. Pain 158:7, pages 1194-1203.
Crossref
Crossref
Caroline A. Browne, Rebecca L. Erickson, Julie A. Blendy & Irwin Lucki. (2017) Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism. Neuropharmacology 117, pages 401-407.
Crossref
Crossref
Cheyenne Allenby & Mary Falcone. (2017) Using Genetics to Improve Addiction Treatment Outcomes. Current Behavioral Neuroscience Reports 4:1, pages 1-9.
Crossref
Crossref
Constance L. Monitto, Myron Yaster & Sabine Kost-Byerly. 2017. Smith's Anesthesia for Infants and Children. Smith's Anesthesia for Infants and Children
423
460.e12
.
D.M.N. Hoofwijk, R.R.I. van Reij, B.P. Rutten, G. Kenis, W.F. Buhre & E.A. Joosten. (2016) Genetic polymorphisms and their association with the prevalence and severity of chronic postsurgical pain: a systematic review. British Journal of Anaesthesia 117:6, pages 708-719.
Crossref
Crossref
Elaine A. Sugarman, Ali Cullors, Joel Centeno & David Taylor. (2016) Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy. Drugs & Aging 33:12, pages 929-936.
Crossref
Crossref
Imen Chatti, Isabelle Creveaux, Jean-Baptiste Woillard, Sarah Langlais, Abdelbasset Amara, Leila Ben Fatma, Ali Saad, Moez Gribaa & Frédéric Libert. (2016) Association of the OPRM1 and COMT genes’ polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?. Therapies 71:5, pages 507-513.
Crossref
Crossref
Manuela De Gregori, Luda Diatchenko, Pablo M. Ingelmo, Valerio Napolioni, Pal Klepstad, Inna Belfer, Valeria Molinaro, Giulia Garbin, Guglielmina N. Ranzani, Giovanni Alberio, Marco Normanno, Federica Lovisari, Marta Somaini, Stefano Govoni, Elisa Mura, Dario Bugada, Thekla Niebel, Michele Zorzetto, Simona De Gregori, Mariadelfina Molinaro, Guido Fanelli & Massimo Allegri. (2016) Human Genetic Variability Contributes to Postoperative Morphine Consumption. The Journal of Pain 17:5, pages 628-636.
Crossref
Crossref
Andrea I. Loewendorf, Anna Matynia, Hakob Saribekyan, Noah Gross, Marie Csete & Mike Harrington. (2016) Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology. Frontiers in Immunology 7.
Crossref
Crossref
Rebecca L Andersen, Daniel J Johnson & Jai N Patel. (2016) Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways. Pharmacogenomics 17:4, pages 417-434.
Crossref
Crossref
Christoph Stein. (2016) Opioid Receptors. Annual Review of Medicine 67:1, pages 433-451.
Crossref
Crossref
A. L. Potapov & A. V. Boyarkina. (2016) Role of μ1-opioid receptor and its genetic polymorphism in patients with cancers. Onkologiya. Zhurnal imeni P.A.Gertsena 5:3, pages 76.
Crossref
Crossref
V Chidambaran, J Mavi, H Esslinger, V Pilipenko, L J Martin, K Zhang & S Sadhasivam. (2014) Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents. The Pharmacogenomics Journal 15:3, pages 255-262.
Crossref
Crossref
Eivor A Laugsand, Frank Skorpen, Stein Kaasa, Rainer Sabatowski, Florian Strasser, Peter Fayers & Pål Klepstad. (2015) Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids. Clinical and Translational Gastroenterology 6:6, pages e90.
Crossref
Crossref
Anna Cieślińska, Edyta Sienkiewicz-Szłapka, Elżbieta Kostyra, Ewa Fiedorowicz, Jadwiga Snarska, Konrad Wroński, Michał Tenderenda, Beata Jarmołowska & Michał Matysiewicz. (2015) μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer. Tumor Biology 36:6, pages 4655-4660.
Crossref
Crossref
Alisa Knapman, Marina Santiago & Mark Connor. (2015)
A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids
in vitro
. British Journal of Pharmacology 172:9, pages 2258-2272.
Crossref
Crossref
Alisa Knapman & Mark Connor. (2015) Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1). British Journal of Pharmacology 172:2, pages 349-363.
Crossref
Crossref
Kenneth Blum, Marlene Oscar-Berman, Zsolt Demetrovics, Debmalya Barh & Mark S. Gold. (2014) Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS). Molecular Neurobiology 50:3, pages 765-796.
Crossref
Crossref
Alisa Knapman, Marina Santiago & Mark Connor. (2014)
Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor
in vitro
. British Journal of Pharmacology 171:18, pages 4273-4288.
Crossref
Crossref
Özlem Solak, Müjgan Özdemir Erdoğan, Handan Yıldız, Alper Murat Ulaşlı, Fatima Yaman, Evrim Suna Arıkan Terzi, Sena Ulu, Ümit Dündar & Mustafa Solak. (2014) Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. Rheumatology International 34:9, pages 1257-1261.
Crossref
Crossref
Maja Matic, Sinno HP Simons, Richard A van Lingen, Joost van Rosmalen, Laure Elens, Saskia N de Wildt, Dick Tibboel & Ron HN van Schaik. (2014)
Rescue morphine in mechanically ventilated newborns associated with combined
OPRM1
and
COMT
genotype
. Pharmacogenomics 15:10, pages 1287-1295.
Crossref
Crossref
Andrew A Somogyi, Daniel T Barratt, Robert L Ali & Janet K Coller. (2014) Pharmacogenomics of methadone maintenance treatment. Pharmacogenomics 15:7, pages 1007-1027.
Crossref
Crossref
Miles D. Thompson, David E. C. Cole, Valerie Capra, Katherine A. Siminovitch, G. Enrico Rovati, W. McIntyre Burnham & Brinda K. Rana. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
189
242
.
Maree T Smith & Arjun Muralidharan. 2001. eLS. eLS.
Ruth Landau, Clemens M. Ortner & Pascal H. Vuilleumier. (2013) The Impact of Genetics and Other Factors on Intra- and Post-partum Pain. Current Anesthesiology Reports 3:4, pages 264-274.
Crossref
Crossref
Carmen Walter, Alexandra Doehring, Bruno G Oertel & Jörn Lötsch. (2013)
µ-opioid receptor gene variant
OPRM1
118 A>G: a summary of its molecular and clinical consequences for pain
. Pharmacogenomics 14:15, pages 1915-1925.
Crossref
Crossref